MaltSci 麦伴科研

Appearance

Popular Reports / pediatrics

This report is written by MaltSci based on the latest literature and research findings

How does autism spectrum disorder develop? ​

Abstract ​

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in social interaction, communication, and behavior. The rising prevalence of ASD has necessitated comprehensive research to understand its developmental pathways and mechanisms. This report explores the multifactorial nature of ASD, emphasizing the roles of genetic, environmental, and neurobiological factors. Genetic studies indicate a strong heritable component, with estimates of heritability between 60% and 90%. Specific genetic mutations, particularly de novo mutations affecting synaptic function, have been identified as contributors to ASD risk. Environmental factors, including prenatal exposures and maternal health, significantly impact the likelihood of developing ASD, with maternal infections and toxins being notable risk factors. Neurobiological investigations reveal structural and functional brain alterations, including imbalances in neurotransmitter systems such as glutamate and GABA, which are critical for normal cognitive and social functioning. Psychosocial factors, including family dynamics and community support, further influence developmental outcomes. This report underscores the importance of early identification and intervention, as understanding the interplay of these factors can inform targeted therapeutic strategies. Future research directions include the integration of advanced technologies and interdisciplinary approaches to uncover the complexities of ASD and develop effective interventions.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Genetic Factors in ASD Development
    • 2.1 Heritability and Family Studies
    • 2.2 Identified Genetic Mutations and Their Implications
  • 3 Environmental Influences on ASD
    • 3.1 Prenatal Factors and Maternal Health
    • 3.2 Postnatal Environmental Exposures
  • 4 Neurobiological Mechanisms
    • 4.1 Brain Structure and Function in ASD
    • 4.2 Neurotransmitter Systems and ASD
  • 5 Psychosocial Factors and Early Development
    • 5.1 Early Behavioral Indicators and Diagnosis
    • 5.2 The Role of Family and Community in Development
  • 6 Current Research Trends and Future Directions
    • 6.1 Emerging Technologies in ASD Research
    • 6.2 Potential Interventions and Therapies
  • 7 Summary

1 Introduction ​

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition that presents significant challenges in social interaction, communication, and behavior. The increasing prevalence of ASD over recent decades has prompted an urgent need for comprehensive research to elucidate its developmental pathways and underlying mechanisms. ASD is characterized by a diverse range of symptoms and severities, making it a complex disorder that cannot be attributed to a single cause. Instead, it arises from an intricate interplay of genetic, environmental, and neurobiological factors that influence brain development and function during critical periods of growth[1].

Understanding the development of ASD is paramount for several reasons. First, early identification and intervention can significantly improve outcomes for affected individuals, enhancing their quality of life and reducing the societal burden associated with the disorder[2]. Second, elucidating the pathways that lead to ASD can inform targeted therapeutic strategies and preventive measures. Recent advancements in genomics and neuroscience have shed light on the genetic mutations and environmental exposures that contribute to the disorder, offering new avenues for research and potential intervention[3].

Current research indicates that genetic factors play a crucial role in the etiology of ASD. Family and twin studies have demonstrated a high heritability of the disorder, suggesting that genetic predispositions significantly influence its development[4]. Moreover, numerous genetic variants have been associated with ASD, implicating pathways involved in synaptic function and neural connectivity[2][5]. However, genetic factors alone do not account for the full spectrum of ASD cases, necessitating a broader examination of environmental influences and their interactions with genetic predispositions[6].

Environmental factors, particularly those occurring during prenatal and early postnatal periods, have also been identified as critical contributors to ASD development. Maternal health, exposure to toxins, and nutritional factors can all impact fetal brain development and may increase the risk of ASD[3]. Additionally, psychosocial factors, including family dynamics and early life experiences, play a significant role in shaping the developmental trajectories of children at risk for ASD[7].

This report is organized into several key sections that address the various dimensions of ASD development. The second section will delve into genetic factors, discussing heritability, family studies, and identified genetic mutations that contribute to the disorder. The third section will focus on environmental influences, examining prenatal factors and postnatal exposures that shape the risk of ASD. The fourth section will explore neurobiological mechanisms, highlighting changes in brain structure and function associated with ASD, as well as the role of neurotransmitter systems. The fifth section will discuss psychosocial factors, emphasizing early behavioral indicators and the influence of family and community on development. The sixth section will outline current research trends and future directions, including emerging technologies and potential interventions. Finally, the report will conclude with a summary of the key findings and implications for future research.

In summary, the development of Autism Spectrum Disorder is a complex interplay of genetic, environmental, and neurobiological factors that warrants thorough investigation. By synthesizing current research findings, this report aims to enhance our understanding of the multifactorial nature of ASD and inform strategies for early identification and intervention. Through this comprehensive overview, we hope to contribute to the ongoing discourse in the field of autism research and ultimately improve outcomes for individuals affected by this challenging disorder.

2 Genetic Factors in ASD Development ​

2.1 Heritability and Family Studies ​

Autism spectrum disorder (ASD) is recognized as a multifactorial neurodevelopmental condition characterized by a range of symptoms including impairments in social communication, repetitive behaviors, and restricted interests. The development of ASD is influenced by a complex interplay of genetic, epigenetic, and environmental factors, with significant heritable components observed in numerous studies.

The heritability of ASD is estimated to be between 60% to 90%, indicating a strong genetic basis for the disorder. Family and twin studies have demonstrated that if one child is diagnosed with ASD, the likelihood of a sibling also being diagnosed is significantly increased. For instance, in twin studies, if one identical twin has ASD, the other twin has a 70% to 90% chance of also having the disorder, whereas the concordance rate in fraternal twins is around 10% to 30% (Yu et al., 2015; Tordjman et al., 2014). This suggests that genetic factors play a crucial role in the etiology of ASD.

Specific genetic mutations and variations have been identified that contribute to the risk of developing ASD. For example, de novo mutations (DNMs), which are new mutations that appear for the first time in one family member, have been implicated in ASD. These mutations can affect genes involved in synaptic function and neural development. The CNTNAP2 gene, for instance, has been associated with language impairment and has been linked to ASD (Rodenas-Cuadrado et al., 2014). Additionally, studies have highlighted the involvement of genes associated with excitatory and inhibitory neuronal function, suggesting that disruptions in these pathways may contribute to the development of ASD symptoms (Antaki et al., 2022).

Moreover, the genetic architecture of ASD is not solely determined by single gene mutations but rather by a polygenic model where multiple genetic factors collectively influence the risk. These genetic factors interact with environmental exposures, leading to variations in symptom severity and presentation among individuals with ASD. For example, the interplay between genetic predispositions and environmental stressors during critical periods of neurodevelopment is a significant area of research (Ayoub, 2025; Bölte et al., 2019).

In conclusion, the development of ASD is influenced by a combination of heritable genetic factors and environmental interactions. Understanding the genetic basis of ASD not only provides insights into its etiology but also has implications for potential therapeutic targets and interventions. Future research efforts are needed to further elucidate the complex genetic underpinnings of ASD and their interactions with environmental factors, which may pave the way for more effective prevention and treatment strategies.

2.2 Identified Genetic Mutations and Their Implications ​

Autism spectrum disorder (ASD) is characterized by a complex interplay of genetic and environmental factors contributing to its development. A significant body of research indicates that genetic factors play a predominant role, with heritability estimates ranging from 40% to 80% [8]. The genetic architecture of ASD is multifaceted, involving both common and rare genetic variants, which can interact with environmental exposures to influence the disorder's manifestation [9].

Numerous studies have identified specific genetic mutations associated with ASD. These include rare monogenic conditions, de novo mutations, copy number variants (CNVs), and single nucleotide variants (SNVs) [10]. The identification of these mutations is critical as they provide insights into the neurodevelopmental mechanisms underlying ASD. For instance, genes implicated by rare variants are often enriched in neuronal processes, highlighting their potential role in the development and function of synapses [11].

Among the genetic factors, the CNTNAP2 gene has been highlighted for its involvement in various neurodevelopmental disorders, including ASD. This gene is associated with a range of phenotypes, indicating that it may play a crucial role in the genetic underpinnings of these conditions [12]. Furthermore, genetic variations can affect synapse formation, neuronal growth, and overall brain development, which are vital processes in the context of ASD [8].

Environmental factors also significantly influence the genetic risk for ASD. Research suggests that environmental exposures, such as advanced parental age, prenatal exposure to teratogens, and other toxic agents, may interact with genetic predispositions to elevate the risk of developing ASD [13]. These interactions may lead to the emergence of deleterious de novo mutations, further complicating the genetic landscape of ASD [9].

The clinical implications of understanding these genetic mutations are profound. By elucidating the genetic etiology of ASD, clinicians can improve genetic diagnosis and intervention strategies, potentially leading to more personalized treatment approaches [14]. This genetic knowledge not only aids in identifying at-risk individuals but also opens avenues for targeted therapies that address specific neurodevelopmental pathways disrupted in ASD [15].

In summary, the development of ASD is significantly influenced by a variety of genetic mutations, which, when combined with environmental factors, shape the disorder's complex phenotype. Ongoing research continues to uncover the intricate relationships between these genetic factors and their implications for understanding, diagnosing, and treating ASD.

3 Environmental Influences on ASD ​

3.1 Prenatal Factors and Maternal Health ​

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition influenced by a combination of genetic and environmental factors. Among these, prenatal factors and maternal health during pregnancy play a critical role in the development of ASD. The evidence suggests that various maternal conditions and exposures during pregnancy can significantly impact the risk of ASD in offspring.

Research indicates that prenatal environmental exposures are essential in understanding the increasing prevalence of ASD. For instance, maternal infections during pregnancy, gestational diabetes, and obesity have been established as significant risk factors. Additionally, emerging studies are examining the effects of maternal medication use, such as selective serotonin reuptake inhibitors (SSRIs) and antibiotics, as well as exposure to environmental toxins, which may disrupt normal brain development and contribute to ASD [16].

A cross-sectional study conducted in Saudi Arabia involving 168 mothers of children diagnosed with ASD revealed that 79.2% of these mothers reported antenatal exposures, including soft drink consumption (79.2%), smoking (35.1%), chronic physical diseases (24.4%), and psychological disorders (20.8%). Notably, significant predictors of severe autism included gestational diabetes (adjusted odds ratio [aOR] 4.553) and birth oxygen desaturation (aOR 4.142), highlighting the profound impact of maternal health on the severity of ASD [17].

Furthermore, maternal immune dysregulation during pregnancy has been linked to ASD. Evidence suggests that a heightened immune response in the mother can affect fetal brain development, potentially leading to autistic traits. Specific fetal brain proteins targeted by maternal autoantibodies have been identified, indicating that maternal immune dysfunction may contribute to the etiology of ASD [18].

In addition to maternal health conditions, psychosocial factors such as maternal stress have also been associated with an increased risk of ASD. Studies indicate that maternal stress susceptibility can interact with prenatal stress exposure, impacting neurodevelopment in offspring. This interplay suggests that multiple environmental exposures may collectively influence the risk of developing ASD [18].

A systematic review of environmental contributions to autism emphasizes that no single factor can account for the disorder. Instead, a multitude of factors—including air pollution, maternal nutrition, and obstetric complications—interact to influence neurodevelopmental outcomes [19]. For example, maternal exposure to pollutants during pregnancy has been correlated with increased ASD risk, suggesting that environmental toxins may disrupt normal brain development [16].

The role of maternal microbiota during pregnancy is also gaining attention. It is hypothesized that an imbalance in maternal gut microbiota could lead to inflammatory responses that affect fetal brain development, thereby increasing the risk of ASD [20]. Interventions aimed at restoring maternal microbiome balance may represent a novel approach to mitigating these risks.

Overall, the development of ASD is a complex interplay of genetic predispositions and a variety of prenatal environmental factors. These factors include maternal health conditions, psychosocial stressors, and environmental exposures, all of which can interact to influence the neurodevelopmental trajectory of the offspring. Continued research is essential to further elucidate these relationships and identify potential preventive strategies.

3.2 Postnatal Environmental Exposures ​

The development of autism spectrum disorder (ASD) is influenced by a complex interplay of genetic and environmental factors, with significant attention given to postnatal environmental exposures. Research indicates that various social and environmental conditions during the early years of life can shape the trajectory of ASD development, potentially interacting with genetic predispositions.

Postnatal environmental factors include social interactions, caregiver behaviors, and exposure to environmental toxins. For instance, caregiver-infant interactions and the quality of early social environments are critical; severe early deprivation may influence the likelihood of developing a full ASD phenotype from an initial prodromal phase [21]. Additionally, studies have shown that social factors such as socioeconomic disadvantage, characterized by lower household income and lone parental status, can exacerbate ASD symptoms [22].

Specific environmental exposures during the postnatal period also play a role. For example, exposure to secondhand tobacco smoke, dampness, and the use of certain heating methods (like oil or kerosene heaters) have been linked to increased ASD symptoms [22]. The evidence suggests that a dose-response relationship exists between the frequency of maternal smoking and the severity of ASD symptoms, indicating that higher exposure correlates with more pronounced outcomes [22].

Moreover, maternal health factors, such as prenatal stress and maternal depression, are significant contributors to postnatal environmental risks. These conditions can influence both the physical and emotional environments in which children develop, thereby affecting their neurodevelopment [22].

Another critical aspect of postnatal influences involves the integration of multiple environmental factors through common mechanistic pathways. For example, exposure to environmental air pollutants, which may occur during both prenatal and postnatal periods, has been shown to contribute to ASD risk [23]. Such exposures can lead to neurodevelopmental alterations that manifest as ASD symptoms, highlighting the need for comprehensive studies that account for the cumulative impact of various environmental exposures [24].

In conclusion, the development of ASD is significantly shaped by postnatal environmental exposures, including social interactions, caregiver behaviors, and environmental toxins. These factors interact with genetic predispositions and can influence the severity and manifestation of ASD symptoms over time. Future research should focus on elucidating the specific mechanisms by which these environmental factors contribute to ASD, particularly through longitudinal studies that track developmental outcomes in relation to exposure histories [21][22].

4 Neurobiological Mechanisms ​

4.1 Brain Structure and Function in ASD ​

Autism spectrum disorder (ASD) is characterized by a range of neurodevelopmental abnormalities that manifest as deficits in social interaction, communication challenges, and restricted patterns of behavior. The development of ASD is influenced by a complex interplay of genetic, environmental, and neurobiological factors that impact brain structure and function.

Research indicates that ASD is associated with significant alterations in brain structure and neural connectivity. Evidence from neuroimaging studies reveals notable structural changes, including variations in brain volume and disrupted neural circuit connectivity. These changes affect both local and global communication within the brain, leading to an imbalance in excitatory and inhibitory neurotransmitter systems, particularly involving glutamatergic and GABAergic pathways. This excitation-inhibition imbalance is a hallmark of ASD and is believed to contribute to the behavioral symptoms observed in affected individuals (Liu et al., 2025; Al Dera, 2022).

Furthermore, genetic and epigenetic research has elucidated familial inheritance patterns and gene-environment interactions that regulate neurodevelopment. Key genes implicated in ASD, such as SH3 and multiple ankyrin repeat domains 3, methyl-CpG binding protein 2, and neurexin 1, have been identified through long-term genetic studies. These genes play crucial roles in neuronal signaling and the development of neural circuits essential for social cognition and behavior (Lim et al., 2022). Epigenetic mechanisms, including DNA methylation and chromatin remodeling, are also thought to be significant in the pathogenesis of ASD, suggesting that environmental exposures can modulate genetic predispositions (Yu et al., 2015).

In addition to genetic and epigenetic factors, alterations in neurodevelopmental processes such as neuritogenesis and axon guidance are believed to contribute to the structural basis of autism pathology. Abnormalities in cytoskeletal rearrangement and disturbances in cell-cell communication during early brain development may underlie the neuroanatomical features associated with ASD (Bakos et al., 2015). The developmental trajectory of the cerebral cortex is particularly important, as alterations in cortical columnar structure and synaptic connectivity have been implicated in the atypical behaviors characteristic of autism (Hutsler & Casanova, 2016).

Moreover, neuroinflammation has been identified as a potential contributing factor in the development of ASD. Immune dysregulation during critical periods of neurodevelopment may lead to neurological dysfunction. Studies have reported abnormal immune responses in autistic individuals, including skewed cytokine profiles and reduced lymphocyte numbers, which may interact with neural development processes (Ashwood et al., 2006).

In summary, the development of autism spectrum disorder involves a multifaceted interaction of genetic, environmental, and neurobiological factors that result in structural and functional abnormalities in the brain. Understanding these mechanisms is essential for advancing diagnostic and therapeutic strategies aimed at improving outcomes for individuals with ASD. The integration of findings from neuroimaging, molecular biology, and genetics highlights the complexity of ASD and underscores the need for personalized treatment approaches that consider the individual variability in neurobiological profiles (Liu et al., 2025; Al Dera, 2022; Hutsler & Casanova, 2016).

4.2 Neurotransmitter Systems and ASD ​

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by impairments in social interaction, communication deficits, and restricted patterns of behavior. The development of ASD is influenced by a myriad of neurobiological mechanisms, particularly involving neurotransmitter systems such as glutamate, gamma-aminobutyric acid (GABA), serotonin, and dopamine.

Neurotransmitter dysregulation is a hallmark of ASD. Evidence suggests that an imbalance between excitatory and inhibitory neurotransmission is crucial in the pathophysiology of the disorder. For instance, studies indicate that glutamatergic and GABAergic pathways are significantly disrupted in individuals with ASD, contributing to an excitation-inhibition imbalance that affects neural circuit connectivity and communication within the brain (Liu et al. 2025; Zhao et al. 2021). This dysregulation may lead to the behavioral symptoms associated with ASD, as proper synaptic transmission is vital for normal cognitive and social functioning.

GABA, the primary inhibitory neurotransmitter in the central nervous system, plays a critical role during neurodevelopment. In early development, GABAergic signaling is essential for neuronal circuit formation and refinement. Dysfunction in GABA signaling can lead to altered excitatory/inhibitory (E/I) balance, which has been implicated in the behavioral deficits observed in ASD patients (Pizzarelli and Cherubini 2011; Zhao et al. 2021). Furthermore, genetic studies have identified variations in genes associated with the GABA system that may contribute to this dysregulation, suggesting a genetic basis for some of the neurobiological abnormalities seen in ASD.

On the other hand, glutamate, as the primary excitatory neurotransmitter, is involved in synaptic plasticity and is critical for learning and memory processes. Abnormalities in glutamatergic signaling can lead to impaired neural connectivity and circuit function, further exacerbating the symptoms of ASD (Jiang et al. 2022). The interaction between glutamate and GABAergic signaling is particularly important, as they work in concert to maintain the E/I balance necessary for optimal brain function.

Additionally, the roles of serotonin and dopamine in ASD have been explored. Serotonin is implicated in mood regulation and social behavior, and alterations in serotonin signaling have been associated with the social deficits characteristic of ASD (Bamicha et al. 2025). Dopamine pathways, particularly those involving the mesocorticolimbic system, are also crucial in regulating reward processing and social interactions, which are often impaired in individuals with ASD (Neuhaus et al. 2010).

In summary, the development of autism spectrum disorder is significantly influenced by neurotransmitter system dysregulation, particularly involving GABA, glutamate, serotonin, and dopamine. The interplay between these neurotransmitter systems is essential for maintaining proper neural circuit function, and their dysfunction contributes to the behavioral and cognitive impairments observed in ASD. Understanding these neurobiological mechanisms provides valuable insights into potential therapeutic targets and interventions for ASD.

5 Psychosocial Factors and Early Development ​

5.1 Early Behavioral Indicators and Diagnosis ​

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by impairments in social interaction, communication deficits, and the presence of restrictive and repetitive behaviors. The development of ASD is influenced by a multitude of factors, including genetic, environmental, and psychosocial elements, which interact dynamically throughout early childhood.

Early behavioral indicators of ASD often manifest in the first years of life, particularly in infants who are at high familial risk, such as those with older siblings diagnosed with the disorder. Prospective studies have identified various behavioral and neurocognitive markers that can predict later clinical symptoms of ASD. These markers include atypical social behaviors, challenges in communication, and variations in play patterns. The identification of these early signs is critical for understanding the developmental pathways leading to ASD and for improving early intervention strategies [25].

The emergence of ASD traits can occur through different developmental trajectories, with some children displaying symptoms early in life while others may not show significant signs until later, particularly around the time of adrenarche (ages 7-10). This period is crucial for the development of social cognition and peer relationships, suggesting that alterations in hormonal and neurological processes during adrenarche may influence the onset and expression of autism traits [26]. For instance, higher levels of dehydroepiandrosterone (DHEA) during middle childhood have been associated with both internalizing and externalizing behaviors, including social anxiety, particularly in girls, and with ASD diagnoses overall [26].

Psychosocial factors also play a significant role in the development of ASD. Parent-child interactions can influence the child's development, with parental behavior impacting social communication and emotional regulation. Stressors within the family environment, including parental psychopathology, can further complicate these interactions and may hinder the child's developmental progress [27]. Additionally, research indicates that resilience factors may exist, allowing some children at risk for ASD to achieve better-than-expected outcomes despite environmental and genetic vulnerabilities [28].

The multifactorial nature of ASD development emphasizes the importance of understanding both genetic predispositions and environmental influences. Genetic factors contribute to the neurodevelopmental vulnerabilities that may predispose a child to ASD, while environmental exposures, such as maternal health during pregnancy and early childhood experiences, can further modulate these risks [1]. Furthermore, factors like oxidative stress and mitochondrial dysfunction have been implicated in the pathogenesis of ASD, suggesting that biochemical and physiological mechanisms are also at play [6].

In summary, the development of Autism Spectrum Disorder is a complex interplay of genetic, environmental, and psychosocial factors. Early behavioral indicators can provide critical insights for diagnosis and intervention, and understanding these dynamics is essential for developing effective strategies to support children with ASD and their families.

5.2 The Role of Family and Community in Development ​

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by impairments in social communication, behavior, and sensory integration. The development of ASD is influenced by a multifactorial interplay of genetic, environmental, and psychosocial factors, particularly during critical periods of early development.

Psychosocial factors, especially those related to family dynamics and community environment, play a significant role in the development of children with ASD. Parental behavior is crucial, as it can either hinder or promote the developmental progress of children with autism. Research indicates that while parents do not cause the social communication difficulties associated with ASD, their interactions can significantly affect the child's development. Stress and impairments in social relatedness can lead to negative transactional effects, which may further impede developmental progress [27]. Conversely, supportive parental behavior can enhance social communication and emotional regulation in children with ASD [27].

Family characteristics, including parental psychopathology, socioeconomic status, and the overall family environment, can also contribute to the developmental trajectory of children with ASD. A study found that various pre- and perinatal factors, including parental psychopathology and family relationships, were associated with the development of autistic traits [29]. This suggests that the family context is not merely a background factor but an active component in shaping the outcomes for children at risk of developing ASD.

Moreover, the broader community context, including social networks and access to services, influences the developmental experiences of children with ASD. For instance, children from families with supportive social networks may have better developmental outcomes compared to those with limited social support [30].

In summary, the development of autism spectrum disorder is significantly affected by psychosocial factors within the family and community. These factors interact with genetic and environmental influences, highlighting the importance of a holistic approach in understanding and supporting children with ASD. Addressing family dynamics and enhancing community resources can potentially improve developmental outcomes for affected children.

6 Current Research Trends and Future Directions ​

6.1 Emerging Technologies in ASD Research ​

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by impairments in social communication, restricted interests, and repetitive behaviors. The development of ASD is believed to arise from a multifactorial interplay of genetic, environmental, and neurobiological factors. Current research trends emphasize the integration of various scientific approaches to elucidate the underlying mechanisms of ASD.

Genetic factors play a significant role in the etiology of ASD. Numerous studies have identified specific genetic mutations and variations associated with increased risk for ASD, suggesting a strong heritable component. These genetic variations often involve synaptic proteins and other molecules critical for neuronal function, which are implicated in the regulation of synaptic development and plasticity. For instance, mutations in genes affecting calcium signaling and synaptic formation have been linked to ASD, highlighting the importance of calcium-regulated signaling pathways in neural development (Krey and Dolmetsch, 2007; Al Dera, 2022) [5][7].

Environmental factors also contribute significantly to the risk of developing ASD. Factors such as prenatal exposure to pollutants, maternal infections, and immune dysregulation have been associated with increased incidence of ASD. Research indicates that exposure to air pollution during pregnancy and early childhood may disrupt normal neurological development, potentially leading to ASD and other developmental disorders (Ha, 2021) [31]. Additionally, neuroinflammatory responses during critical periods of brain development may further exacerbate genetic vulnerabilities, leading to the manifestation of ASD symptoms (Ayoub, 2025) [1].

Recent advancements in technology have facilitated a deeper understanding of the neurobiological underpinnings of ASD. Techniques such as longitudinal MRI have been utilized to study brain growth patterns in individuals with ASD, revealing abnormalities in growth rates of specific brain regions associated with social and communicative functions (Hua et al., 2013) [32]. Moreover, the application of eye-tracking technology has shed light on the cognitive processes underlying language production and social interaction deficits in children with ASD, providing insights into their unique developmental trajectories (Norbury, 2014) [33].

Furthermore, emerging technologies, including gene editing tools like CRISPR, are being explored to manipulate genetic factors in model organisms, such as zebrafish, to study neuronal connectivity and the effects of environmental toxins on brain development (Miller et al., 2018) [34]. These models allow researchers to investigate the interactions between genetic predispositions and environmental exposures, offering a comprehensive view of ASD pathogenesis.

In summary, the development of ASD is a result of intricate interactions between genetic and environmental factors, with ongoing research focusing on identifying specific molecular mechanisms and utilizing innovative technologies to advance understanding and potential interventions. Future directions in ASD research will likely continue to leverage these technologies to unravel the complexities of its etiology and develop targeted therapeutic strategies.

6.2 Potential Interventions and Therapies ​

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by difficulties in social interaction, communication, and the presence of restricted and repetitive behaviors. The development of ASD is influenced by a multifactorial etiology, which includes both genetic and environmental factors. Recent research has made significant strides in understanding the mechanisms underlying ASD, leading to potential interventions and therapies.

Over the past two decades, the prevalence of ASD has increased, and despite this rise, clear diagnostic markers and specifically targeted medications remain elusive. Advances in human genomics have identified numerous genetic variations associated with ASD, which are being validated through various approaches, including animal models. These studies have highlighted key mechanisms related to synaptic dysfunctions that contribute to the pathogenesis of ASD (Won et al., 2013; Wang et al., 2023) [2][35].

The exploration of risk factors for ASD has evolved to include both genetic predispositions and environmental triggers. Research has shown that genetic factors account for a significant heritability of ASD, but there is a growing interest in understanding how environmental influences interact with these genetic factors to contribute to the disorder's development (Gyawali & Patra, 2019) [36]. Furthermore, the variability in ASD symptoms among individuals is attributed to dynamic interactions between biological and non-biological risk factors, which evolve over time (Elsabbagh, 2020) [28].

Current research trends emphasize the importance of multidisciplinary approaches to ASD, integrating findings from genetics, neurobiology, and behavioral sciences. For instance, studies have focused on abnormal synaptic signaling pathways, gene transcription, and the brain-gut axis, providing a theoretical basis for precision therapies targeting these specific mechanisms (Wang et al., 2023; Jiang et al., 2022) [35][37].

Potential interventions and therapies for ASD have traditionally centered on behavioral approaches, but recent advancements in noninvasive brain modulation techniques have shown promise. Techniques such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are being investigated for their ability to modify neuroplasticity and improve cognitive and behavioral outcomes in individuals with ASD. Preliminary evidence suggests that these noninvasive methods may provide therapeutic benefits, although more extensive studies are needed to establish their clinical significance and long-term effects (Griff et al., 2023) [38].

In conclusion, the development of ASD is a complex interplay of genetic and environmental factors, with ongoing research focused on elucidating the underlying mechanisms and identifying effective interventions. As the field continues to evolve, the integration of findings from various disciplines will be crucial in advancing our understanding of ASD and improving treatment strategies.

7 Conclusion ​

The development of Autism Spectrum Disorder (ASD) is a multifaceted process influenced by an intricate interplay of genetic, environmental, and neurobiological factors. Key findings indicate that genetic heritability plays a significant role, with estimates suggesting a heritability range of 60% to 90%. Identified genetic mutations, particularly those affecting synaptic function and neural connectivity, provide insights into the neurodevelopmental mechanisms underlying ASD. Environmental influences, especially prenatal exposures and maternal health, significantly contribute to ASD risk, highlighting the importance of early life conditions. Neurobiological studies reveal alterations in brain structure and neurotransmitter systems, particularly an imbalance between excitatory and inhibitory pathways, which are critical for social and cognitive functions. Psychosocial factors, including family dynamics and community support, further shape the developmental trajectories of children with ASD. As research progresses, emerging technologies and multidisciplinary approaches are paving the way for targeted interventions and therapies, emphasizing the need for personalized treatment strategies. Future research should continue to explore the complex interactions among genetic, environmental, and psychosocial factors to enhance understanding and improve outcomes for individuals with ASD.

References ​

  • [1] George Ayoub. Autism Spectrum Disorder as a Multifactorial Disorder: The Interplay of Genetic Factors and Inflammation.. International journal of molecular sciences(IF=4.9). 2025. PMID:40650268. DOI: 10.3390/ijms26136483.
  • [2] Hyejung Won;Won Mah;Eunjoon Kim. Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.. Frontiers in molecular neuroscience(IF=3.8). 2013. PMID:23935565. DOI: 10.3389/fnmol.2013.00019.
  • [3] Li Yu;YiMing Wu;Bai-Lin Wu. Genetic architecture, epigenetic influence and environment exposure in the pathogenesis of Autism.. Science China. Life sciences(IF=9.5). 2015. PMID:26490976. DOI: 10.1007/s11427-015-4941-1.
  • [4] Brian J O'Roak;Matthew W State. Autism genetics: strategies, challenges, and opportunities.. Autism research : official journal of the International Society for Autism Research(IF=5.6). 2008. PMID:19360646. DOI: 10.1002/aur.3.
  • [5] Jocelyn F Krey;Ricardo E Dolmetsch. Molecular mechanisms of autism: a possible role for Ca2+ signaling.. Current opinion in neurobiology(IF=5.2). 2007. PMID:17275285. DOI: 10.1016/j.conb.2007.01.010.
  • [6] Musthafa Mohamed Essa;Selvaraju Subash;Nady Braidy;Samir Al-Adawi;Chai K Lim;Tamilarasan Manivasagam;Gilles J Guillemin. Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.. International journal of tryptophan research : IJTR(IF=4.1). 2013. PMID:23922500. DOI: 10.4137/IJTR.S11355.
  • [7] Hussain Al Dera. Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2022. PMID:35149383. DOI: 10.1016/j.biopha.2022.112688.
  • [8] Farhad Mashayekhi;Zivar Salehi. Autism spectrum disorder genetics; a comprehensive review.. Reviews in the neurosciences(IF=4.1). 2025. PMID:40700716. DOI: 10.1515/revneuro-2025-0040.
  • [9] Kealan Pugsley;Stephen W Scherer;Mark A Bellgrove;Ziarih Hawi. Environmental exposures associated with elevated risk for autism spectrum disorder may augment the burden of deleterious de novo mutations among probands.. Molecular psychiatry(IF=10.1). 2022. PMID:34002022. DOI: 10.1038/s41380-021-01142-w.
  • [10] Ece D Gamsiz;Laura N Sciarra;Abbie M Maguire;Matthew F Pescosolido;Laura I van Dyck;Eric M Morrow. Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics(IF=6.9). 2015. PMID:26105128. DOI: 10.1007/s13311-015-0363-9.
  • [11] Danny Antaki;James Guevara;Adam X Maihofer;Marieke Klein;Madhusudan Gujral;Jakob Grove;Caitlin E Carey;Oanh Hong;Maria J Arranz;Amaia Hervas;Christina Corsello;Keith K Vaux;Alysson R Muotri;Lilia M Iakoucheva;Eric Courchesne;Karen Pierce;Joseph G Gleeson;Elise B Robinson;Caroline M Nievergelt;Jonathan Sebat. A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex.. Nature genetics(IF=29.0). 2022. PMID:35654974. DOI: 10.1038/s41588-022-01064-5.
  • [12] Pedro Rodenas-Cuadrado;Joses Ho;Sonja C Vernes. Shining a light on CNTNAP2: complex functions to complex disorders.. European journal of human genetics : EJHG(IF=4.6). 2014. PMID:23714751. DOI: 10.1038/ejhg.2013.100.
  • [13] Sven Bölte;Sonya Girdler;Peter B Marschik. The contribution of environmental exposure to the etiology of autism spectrum disorder.. Cellular and molecular life sciences : CMLS(IF=6.2). 2019. PMID:30570672. DOI: 10.1007/s00018-018-2988-4.
  • [14] Yue Zhang;Xuanshi Liu;Ruolan Guo;Wenjian Xu;Qi Guo;Chanjuan Hao;Xin Ni;Wei Li. Biological implications of genetic variations in autism spectrum disorders from genomics studies.. Bioscience reports(IF=4.7). 2021. PMID:34240107. DOI: 10.1042/BSR20210593.
  • [15] Heather Way;Grant Williams;Sharon Hausman-Cohen;Jordan Reeder. Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes.. Journal of personalized medicine(IF=3.0). 2021. PMID:34202628. DOI: 10.3390/jpm11070596.
  • [16] Chloe Love;Luba Sominsky;Martin O'Hely;Michael Berk;Peter Vuillermin;Samantha L Dawson. Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms.. BMC medicine(IF=8.3). 2024. PMID:39278907. DOI: 10.1186/s12916-024-03617-3.
  • [17] Ahmed Abdelkader;Faten AlRadini;Ashwaq Alosaimi;Abdallah Abbas;Zaki Judeh;Tahneed Emy Abu Esaid;Alaa Saleh;Jaffer Shah;Samar Amer. Unveiling the influences of prenatal and maternal factors on the journey of an autistic child.. Frontiers in psychiatry(IF=3.2). 2024. PMID:39758437. DOI: 10.3389/fpsyt.2024.1467821.
  • [18] David Q Beversdorf;Hanna E Stevens;Karen L Jones. Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders.. Current psychiatry reports(IF=6.7). 2018. PMID:30094645. DOI: 10.1007/s11920-018-0945-4.
  • [19] Irva Hertz-Picciotto;Rebecca J Schmidt;Paula Krakowiak. Understanding environmental contributions to autism: Causal concepts and the state of science.. Autism research : official journal of the International Society for Autism Research(IF=5.6). 2018. PMID:29573218. DOI: 10.1002/aur.1938.
  • [20] Sylvie Mavel;Léa Pellé;Christian R Andres. Impact of maternal microbiota imbalance during pregnancy on fetal cerebral neurodevelopment: Is there a link to certain autistic disorders?. Brain, behavior, & immunity - health(IF=3.5). 2025. PMID:40776983. DOI: 10.1016/j.bbih.2025.101074.
  • [21] William Mandy;Meng-Chuan Lai. Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition.. Journal of child psychology and psychiatry, and allied disciplines(IF=7.0). 2016. PMID:26782158. DOI: 10.1111/jcpp.12501.
  • [22] Cindy Pham;Christos Symeonides;Martin O'Hely;Peter D Sly;Luke D Knibbs;Sarah Thomson;Peter Vuillermin;Richard Saffery;Anne-Louise Ponsonby; . Early life environmental factors associated with autism spectrum disorder symptoms in children at age 2 years: A birth cohort study.. Autism : the international journal of research and practice(IF=5.6). 2022. PMID:35012378. DOI: 10.1177/13623613211068223.
  • [23] Marie-Claire Flores-Pajot;Marianna Ofner;Minh T Do;Eric Lavigne;Paul J Villeneuve. Childhood autism spectrum disorders and exposure to nitrogen dioxide, and particulate matter air pollution: A review and meta-analysis.. Environmental research(IF=7.7). 2016. PMID:27609410. DOI: 10.1016/j.envres.2016.07.030.
  • [24] Torkel Carlsson;Mina Rosenqvist;Agnieszka Butwicka;Henrik Larsson;Sebastian Lundström;Pei-Yin Pan;Karl Lundin Remnélius;Mark J Taylor;Sven Bölte. Association of cumulative early medical factors with autism and autistic symptoms in a population-based twin sample.. Translational psychiatry(IF=6.2). 2022. PMID:35194015. DOI: 10.1038/s41398-022-01833-0.
  • [25] Emily J H Jones;Teodora Gliga;Rachael Bedford;Tony Charman;Mark H Johnson. Developmental pathways to autism: a review of prospective studies of infants at risk.. Neuroscience and biobehavioral reviews(IF=7.9). 2014. PMID:24361967. DOI: .
  • [26] Cory Szakal;Bernard Crespi. Adrenarche, social cognition, and the development and evolution of autism spectrum traits.. Frontiers in psychiatry(IF=3.2). 2025. PMID:40995076. DOI: 10.3389/fpsyt.2025.1576392.
  • [27] Judith A Crowell;Jennifer Keluskar;Amanda Gorecki. Parenting behavior and the development of children with autism spectrum disorder.. Comprehensive psychiatry(IF=4.2). 2019. PMID:30658339. DOI: 10.1016/j.comppsych.2018.11.007.
  • [28] Mayada Elsabbagh. Linking risk factors and outcomes in autism spectrum disorder: is there evidence for resilience?. BMJ (Clinical research ed.)(IF=42.7). 2020. PMID:31992555. DOI: 10.1136/bmj.l6880.
  • [29] Masoud Amiri;Sander Lamballais;Eloy Geenjaar;Laura M E Blanken;Hanan El Marroun;Henning Tiemeier;Tonya White. Environment-Wide Association Study (En WAS) of Prenatal and Perinatal Factors Associated With Autistic Traits: A Population-Based Study.. Autism research : official journal of the International Society for Autism Research(IF=5.6). 2020. PMID:32830427. DOI: 10.1002/aur.2372.
  • [30] Marsha Mailick;Teresa Bennett;Leann Smith DaWalt;Maureen S Durkin;Gordon Forbes;Patricia Howlin;Catherine Lord;Anat Zaidman-Zait;Lonnie Zwaigenbaum;Vanessa Bal;Somer Bishop;Chung-Hsin Chiang;Adriana DiMartino;Christine M Freitag;Stelios Georgiades;Matthew Hollocks;Meng-Chuan Lai;Matthew J Maenner;Patrick S Powell;Julie Lounds Taylor;Alycia Halladay. Expanding Research on Contextual Factors in Autism Research: What Took Us So Long?. Autism research : official journal of the International Society for Autism Research(IF=5.6). 2025. PMID:39902495. DOI: 10.1002/aur.3312.
  • [31] Sandie Ha. Air pollution and neurological development in children.. Developmental medicine and child neurology(IF=4.3). 2021. PMID:33300118. DOI: 10.1111/dmcn.14758.
  • [32] Xue Hua;Paul M Thompson;Alex D Leow;Sarah K Madsen;Rochelle Caplan;Jeffry R Alger;Joseph O'Neill;Kishori Joshi;Susan L Smalley;Arthur W Toga;Jennifer G Levitt. Brain growth rate abnormalities visualized in adolescents with autism.. Human brain mapping(IF=3.3). 2013. PMID:22021093. DOI: 10.1002/hbm.21441.
  • [33] Courtenay Frazier Norbury. Sources of variation in developmental language disorders: evidence from eye-tracking studies of sentence production.. Philosophical transactions of the Royal Society of London. Series B, Biological sciences(IF=4.7). 2014. PMID:24324237. DOI: 10.1098/rstb.2012.0393.
  • [34] Galen W Miller;Vidya Chandrasekaran;Bianca Yaghoobi;Pamela J Lein. Opportunities and challenges for using the zebrafish to study neuronal connectivity as an endpoint of developmental neurotoxicity.. Neurotoxicology(IF=3.9). 2018. PMID:29704525. DOI: 10.1016/j.neuro.2018.04.016.
  • [35] Ling Wang;Binquan Wang;Chunyan Wu;Jie Wang;Mingkuan Sun. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy.. International journal of molecular sciences(IF=4.9). 2023. PMID:36768153. DOI: 10.3390/ijms24031819.
  • [36] Shreeya Gyawali;Bichitra Nanda Patra. Autism spectrum disorder: Trends in research exploring etiopathogenesis.. Psychiatry and clinical neurosciences(IF=6.2). 2019. PMID:31077508. DOI: 10.1111/pcn.12860.
  • [37] Chen-Chen Jiang;Li-Shan Lin;Sen Long;Xiao-Yan Ke;Kohji Fukunaga;Ying-Mei Lu;Feng Han. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.. Signal transduction and targeted therapy(IF=52.7). 2022. PMID:35817793. DOI: 10.1038/s41392-022-01081-0.
  • [38] Jessica R Griff;Jake Langlie;Nathalie B Bencie;Zachary J Cromar;Jeenu Mittal;Idil Memis;Steven Wallace;Alexander E Marcillo;Rahul Mittal;Adrien A Eshraghi. Recent advancements in noninvasive brain modulation for individuals with autism spectrum disorder.. Neural regeneration research(IF=6.7). 2023. PMID:36453393. DOI: 10.4103/1673-5374.360163.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Autism Spectrum Disorder · Genetic Factors · Environmental Influences · Neurobiological Mechanisms · Early Intervention

© 2025 MaltSci